News

The new program seeks to connect GLP-1 management with primary care and Amazon Pharmacy in one place, according to the company.

The company expects to file for regulatory approval of a label expansion for Ozempic pills in the United States and Rybelsus in the European Union in the second half of this year.

Brokers "provide an incredibly valuable service," but "we've got to be able to trust them," James Gelfand testified.

Elevance, Anthem's parent, hopes simpler plans and AI will moderate the impact of cost cuts.

A top insurance industry risk math expert has designed two new ETFs for that purpose.

More than 7 in 10 physicians now report using AI in clinical practice, up from 48% last year.